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Summary
Antibody-mediated CD4 crosslinking results in increased tyrosine phosphorylation and tyrosine
kinase activity of the associated p56". Treatment with anti-CD4 and anti-Ig also induced the
phosphorylation of p56kk in a CD45- mutant cell line, indicating that the increase in
phosphotyrosine content of p56kk is not the result of being sequestered from CD45 protein
tyrosine phosphatase (PTPase). Antibody-mediated coclustering of CD45 with CD4 inhibited
the anti-CD4-induced phosphorylation of p56" on tyrosine and the concomitant increase in
in vitro kinase activity. Similar results were obtained when CD45 was coclustered with CD8
on cytotoxic T cell lines. These observations provide strong evidence that p56kk is a substrate
for CD45 in vivo and provide an assay to study the regulation and specificity ofCD45 PTPase activity.
C
D45 (T200, LCA) is a family of high molecular weight
glycoproteins expressed exclusively on cells of hemato-
poietic origin (for review, see reference 1). CD45 has a large
highly conserved cytoplasmic domain of -705 amino acids
that contains two related subdomains. These subdomains have
30-40% identity with a placental protein tyrosine phospha-
tase (PTPase) (2), and CD45 has been shown to have PTPase
activity (3, 4).
We have previously found that the src-related tyrosine ki-
nase p50 was more heavily phosphorylated on tyrosine in
CD45- mutant T lymphomas, suggesting that p5V is an
in vivo substrate for CD45 (4). p56" is a tyrosine kinase ex-
pressed predominantly in T cells and associated with CD4
and CD8, molecules expressed on T cells that are restricted
by class II and class I MHC, respectively (5-7). Recently,
Veillette et al. (8, 9) have shown that when CD4 or CD8
is clustered with antibodies, there is an increase in both tyro-
sine phosphorylation and kinase activity of p50. Herein,
we have investigated whether, and under what circumstances,
CD45 can modulate this process. We show that coclustering
of CD45 with CD4 or CD8 leads to dephosphorylation of
p56" and concomitantly inhibits the increase in p56kk in
vitro kinase activity. This provides further evidence that
p56" associated with CD4 or CD8 is an in vivo substrate
of CD45, and suggests one possible mechanism by which
CD45 may modulate T cell responsiveness.
Materials and Methods
Cell Lines and Antibodies.
￿
The CD45' parental and CD45-
mutant SAKRTLS 12.1 cell lines (4), the CD4' Th hybridoma
AODH 7.1 (10), and the I1,2-dependent CD8' cytotoxic cell line
347
L3AI (11) are previouslydescribed murine lymphoid cell lines. L3AI
is a variant that has been maintained in 11,2 without antigen stim-
ulation but still maintains its antigen specificity and cytotoxic func-
tion. The mAb 13/2.3 is specific for murine CD45 (12). The mAbs
R17 217.2, directed against the transferrin receptor (TR), GK1.5,
directed against CD4, and 53.6.72, directed against CD8, were
obtained through the American Type Culture Collection (Rock-
ville, MD).
Antibody Clustering and Immunoprecipitations. Cells were in-
cubated at 10'/ml in serum-free DMEM in the presence of 5-10
Ecg/ml antibody for 30 min on ice. Cells were then washed once
in serum-free DMEM and resuspended in DMEM at 4 x 10'/ml.
10 Al ofrabbitanti-rat Ig antisera (United States Biochemicals Corp.,
Cleveland, OH) was added, and the cells were incubated for 2-15
min at 37°C. For blots of total cell lysates, the cells were pelleted
and lysed in boiling 0.5% SDS in 10 mM Tris-HCI (pH 8.0). DNA
in the samples was then sheared by passing several times through
a 22-gauge needle. An equal volume of 2 x Laemmli SDS-elec-
trophoresis sample buffer was added, and the sample was boiled
again. For immunoprecipitations, the cells were lysed in 1% NP-
40/10 mM Tris-HCI (pH 8.0)/150 mM NaCl. Lysates were clarified
by centrifugation for 10 min in a microfuge and then im-
munoprecipitates prepared with an anti-p5611 antiserum (13),
generously provided by Dr. Bart Sefton (The Salk Institute). Im-
munoprecipitates were subsequently washed threetimes with 0.5%
NP-40 in the same buffer and twice with buffer alone.
Immunoblots.
￿
Samples containing 1-2 x 106 cell equivalents
were subjected to electrophoresis on an SDS/8.5% polyacrylamide
gel. Proteins were then transferred to Immobilon-P (Millipore Con-
tinental Water Systems, Bedford, MA) in 20% methanol/20 mM
Tris base/96 mM glycine for 2-3 h at 60 V in a transfer apparatus
(Bio-Rad Laboratories, Richmond, CA). Immunoblotting was per-
formed with rabbit anti-p56k' antiserum (13) or affinity-purified
rabbit antiphosphotyrosine antiserum (4) and detected with 1151-
labeled protein A (ICN, Irvine, CA). Prestained SDS electropho-
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were used as standards.
Kinase Assays . Immunoprecipitated samples prepared as de-
scribed above were incubated in kinase buffer (10mM Pipes, pH
7.2/10 mM MnC1Z) containing 5 AC1 of y-["P]ATP (ICN) for
10-20 min at 30°C . To stop the reaction, an equal volume of 2x
reducing Laemmli SDS-electrophoresis sample buffer was added,
and the samples were immediately boiled for 2 min. The samples
were subjected to electrophoresis on an SDS/10%a polyacrylamide
gel . Gels were stained in Coomassie blue, dried, and exposed to
X-omat film for 10-30 min at room temperature .
Results
CD45 Is not Requiredfor Phosphorylation ofp56" Induced
by CD4 or CD8 Clustering. As previously reported (8, 9),
crosslinking ofCD4 on the cell surface with an anti-CD4
mAb and second anti-Ig antibody leads to a rapid increase
in the tyrosine phosphorylation of p56", as detected by
immunoblotting of total cell proteins (data not shown) or
anti-p56kk immunoprecipitates with antiphosphotyrosine an-
tibodies (Fig. 1 A) . IfCD45 were normally to play a regula-
tory role in maintaining a low basal level ofphosphorylation
of p56kk, then clustering of CD4/p56kk or CD8/p56" com-
plexes might sequester p56kk from the CD45 FTpase, and
lead to the observed increase in the phosphotyrosine content
of p56" . To investigate this possibility, CD4 was clustered
on the surface of CD45- mutant and CD45+ parental
SAKRTLS 12.1 cells, and the effects on the phosphorylation
of p56" were analyzed . As shown in Fig . 1, antibody cross-
linking of CD4 on the surface of SAKRTLS 12.1 CD45-
cells induced a similar increase in the phosphotyrosine con-
tent of p56kk and its kinase activity, as in the CD45+ pa-
rental cells. This indicates CD45 is not required to observe
this effect and that CD4 mAb crosslinking is not merely se-
questeringp56" from the CD45 phosphatase domains, thus
inducing an increase in phosphotyrosine content .
Coclustering ofCD45 with CD4 Inhibits CD4-induced Phos-
phorylation ofp56kk. We then determined if coclustering
CD45 with CD4 in these SAKRTLS 12.1 cell lines had any
effect on the increased tyrosine phosphorylation ofp56" in-
duced byCD4 clustering . Fig . 1A clearly demonstrates that
when CD45 is cocrosslinked with CD4, there is no longer
an increase in tyrosine phosphorylation . Immunoblotting of
replicate samples of immunoprecipitates with anti-p56" an-
tibodies confirmed that they contained equal amounts of
p56kk (data not shown) . The change in phosphotyrosine
content of p56kk was also associated with a concomitant in-
crease in kinase activity of p56", as determined by in vitro
autophosphorylation (Fig. 1 B) . A similar though less dra-
matic increase in the ability ofp56U to phosphorylate eno-
lase in vitro was also observed (data not shown) . Clustering
of CD45 alone had no direct effect on either the tyrosine
phosphorylation of p56kk nor its in vitro kinase activity.
However, cocrosslinking ofCD45 withCD4 completely abol-
ished the increase in phophorylation on tyrosine of p56kk
and the increase in kinase activity induced by anti-CD4mAbs
alone. This effect was specific, as coclustering of CD4 with
348 CD45 Can Dephosphorylate p56kk In Vitro
Figure 1 .
￿
Effect of antibody crosslinking on the tyrosine phos-
phorylation and kinase activity of p56kk from CD45' and CD45 -
SAKRTLS 12 .1 cells . (A) Antiphosphotyrosine blots of p50 im-
munoprecipitates from CD45` and CD45 - SAKRTLS 12 .1 cells after
crosslinking with anti-CD4 or anti-CD45 alone or in combination.
Second antibody alone was used as a negative control, (B) Kinase ac-
tivity of p56kk from cells treated as in A . AntiTR mAb was used as
a control .
the transferrin receptor did not reduce the anti-CD4 mAb-in-
duced increase in phosphorylation of p56kk (data not shown)
or the associated increase in in vitro kinase activity (Fig. 1 B) .
The observation that CD45 can inhibit the phosphoryla-
tion on tyrosine of p56kk stimulated by CD4 crosslinking
is not restricted to SAKRTLS 12.1 cells . As shown in Fig .
2 A, the same result was obtained if CD4 and CD45 were
crosslinked on AODH 7.1 cells, a Th hybridoma, and two
other CD4+ functional Th cell lines . In addition, cocross-
linking ofCD8 with CD45 on the cytotoxicT cell line L3AI
also inhibits the phosphorylation ofp56" induced by cross-
linking withCD8 mAbs alone (Fig. 2 B) . Similar results were
obtained with three other cytotoxic T cell lines (data not
shown) .Figure 2 .
￿
Antiphosphotyrosine blots of total cell lysates prepared
from functional T cell lines after antibody crosslinking . The Th hy-
bridoma AODH 7 .1 and the cytotoxic T cell line L3AI were cross-
linked with anti-CD4 or anti-CD8 antibodies, respectively, either
alone or together with anti-CD45 antibodies.
It is possible that coclustering CD4 or CD8 with CD45
could inhibit phosphorylation by an indirect mechanism such
as steric hindrance, and not by the action of CD45 PTPase .
To investigate this issue, we first induced phosphorylation
of p56kk on tyrosine by crosslinking with anti-CD4 mAbs
alone and subsequently coclustered CD45 to determine
whether CD45 can dephosphorylate p56kk under these cir-
cumstances. The results of such an experiment are shown
in Fig. 3 . AODH 7.1 cells were treated at 4°C for 30 min
with anti-CD4 mAb, washed, and incubated with anti-Ig
antibodies at 37°C for an additional 2 min . One replicate
sample of cells was then immediately boiled in electropho-
resis sample buffer (Fig. 3, lane 2), another incubated for an
additional 13 min at 37°C (lane 4), and a third incubated
for 13 min at 37°C after the addition of anti-CD45 mAb
(lane 6) . Other controls included cells incubated for a total
of 15 min for 37°C with anti-Ig alone (Fig . 3, lane 1), or
with anti-CD45 and anti-Ig (lane 7) . Treatment with anti-
CD4mAb and anti-Ig for 2 min at 37°C induced a dramatic
increase in phosphorylation ofp56" (Fig. 3, lane 2) that was
sustained during the 15-min incubation (lane 4) . Addition
of anti-CD45 mAbs at 2 min, however, almost completely
reversed the increase in phosphorylation ofp56" induced by
clustering of CD4/p56" complexes . This result strongly
suggests that coclustering ofCD45 with CD4 leads directly
to the dephosphorylation ofp56" . Conversely, coclustering
ofCD4 and CD45 neither induces phosphorylation ofCD45
on tyrosine that could be detected by immunoblotting with
antiphosphotyrosine antibodies nor alters the in vitro PTPase
activity ofCD45, indicating that p56kk does not act recipro-
cally on CD45 (data not shown) .





Reversal of increased tyrosine phosphorylation of p50k
induced by CD4 clustering by coclustering with anti-CD45 mAb.
AODH 7 .1 cells were crosslinked with anti-CD4 mAb (GK 1.5) and
anti-Ig to induce tyrosine phosphorylation of p56U . After induction
for 2 min, anti-CD45 mAb (13/2) was added, and the cells were in-
cubated for an additional 13 min. Controls of anti-CD4 alone, anti-
CD45 alone, and anti-CD4 with anti-CD45 together were also done.
(Lane 1) Second antibody alone for 15 min; (lane 2) anti-CD4 for 2
min; (lane 3) anti-CD4 with anti-CD45 for 2 min ; (lane 4) anti-CD4
for 15 min ; (lane S) anti-CD4 with anti-CD45 for 15 min ; (lane 6)
anti-CD4 for 2 min, then addition of anti-CD45 with a further 13-
min incubation; (lane 7) anti-CD45 for 15 min .
Discussion
The demonstration that clustering ofCD45 with CD4/
p56" and CD8/p56kk complexes results in the dephosphor-
ylation of p56kk is important for several reasons . First, it pro-
vides additional evidence that p56kk can serve as a substrate
for CD45 in vivo . Second, it raises the possibility that one
mechanism by which the action ofCD45 may be regulated
during T cell activation or other physiological responses is
by redistribution in the cell membrane that brings CD45 into
close proximity with a specific substrate. Such a rearrange-
ment might involve molecular interactions between the ex-
ternal domain ofCD45 and other cell membrane molecules
either on the same cell or an adjacent cell . Finally, antibody-
mediated coclustering ofCD45 with CD4 or other cellmem-
brane molecules provides an in vivo assay to investigate the
specificity of CD45 PTPase activity and its regulation . For
example, crosslinking ofCD45 with the receptor for epidermal
growth factor (EGF) expressed in a human Burkitt's lym-
phoma cell line (14) does not inhibit the autophosphoryla-
tion of the receptor induced by EGF binding (Ostergaard,
H.L.,R. Taetle, S. Smedrud, and 1 . Txowbridge, unpublished
results) . Further, crosslinking ofCD45 with the I1r2-R does
not inhibit the increased protein tyrosine phosphorylation
induced by IL2 binding (D. Shackelford, personal commu-
nication) . Both of these results indicate that coclustering of
CD45 with phosphotyrosine-containing proteins is not
sufficient for their dephosphorylation and suggest that CD45
has restricted substrate specificity in vivo .References
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